Each strain/condition is assayed in 6 technical replicate wells per plate across 3 independent biological replicates (separate overnight cultures on separate days). Edge wells are filled with sterile medium and excluded from analysis to avoid evaporation artifacts. A planktonic growth control (OD600 of the supernatant) is read before staining to allow biomass normalization (CV/OD600). Time points at 24 h and 48 h capture maturation. Plate layout is randomized so conditions are not confounded with plate position.
BSL-2 for P. aeruginosa (opportunistic pathogen); handle in a Class II biosafety cabinet and avoid aerosols. PPE: lab coat, nitrile gloves, safety glasses. Crystal violet is a mutagen and skin/eye irritant; glacial/30% acetic acid is corrosive and volatile — handle in a fume hood and avoid inhalation. Collect CV and acetic acid waste in a designated hazardous-waste container; do not pour down the drain. Autoclave or bleach-treat all bacterial waste.
Negative/abiotic control: medium-only wells (no bacteria), processed identically, defining background CV staining to subtract. Biofilm-deficient control: a known low-biofilm mutant (e.g., flgK or pilA) or wild-type treated with 0.5 mM EDTA, expected to stain weakly. Positive control: untreated wild-type PAO1 at peak biofilm. Vehicle control: wells receiving the test-compound solvent (e.g., DMSO <=1%) without compound. Sterility control wells confirm medium is uncontaminated.
Wild-type PAO1 typically yields CV OD595 of 1.0-3.0 (background-subtracted) at 24 h, rising at 48 h. Biofilm-deficient controls <0.3. A clear visible violet ring at the air-liquid interface and well bottom in positive wells. CV/OD600 normalization should distinguish reduced biofilm from simple growth inhibition. Coefficient of variation across technical replicates ideally <20%.
To measure adherent biofilm biomass of P. aeruginosa PAO1 grown statically in 96-well polystyrene plates by staining total attached biomass with 0.1% crystal violet, solubilizing the bound dye, and reading absorbance at OD550-595. The assay provides a semi-quantitative, high-throughput readout of biofilm formation suitable for strain comparisons and anti-biofilm compound screening.
Independent variable: strain/genotype or test treatment (compound concentration, time point). Dependent variable: CV-stained biofilm biomass (OD595, background-subtracted, optionally normalized to planktonic OD600). Controlled variables: inoculum density (OD600 0.05), medium composition, static incubation at 37 C, wash number/volume, stain concentration and time, solubilizer, and read wavelength.
Wild-type P. aeruginosa PAO1 will form robust biofilm yielding CV OD595 >=4x the abiotic background, while a biofilm-deficient control (e.g., a flagellar/pili mutant or DNase/EDTA treatment) will show significantly reduced staining. Sub-inhibitory test treatments that disperse or inhibit biofilm will reduce normalized CV signal in a dose-dependent manner.
Subtract mean abiotic-control OD595 from each test well. Average technical replicates per biological replicate, then average across biological replicates. Optionally normalize biofilm to planktonic growth (CV OD595 / supernatant OD600) to separate biofilm-specific effects from growth effects. Plot mean +/- SD; for dose-response, fit a four-parameter logistic curve in GraphPad Prism or Python (scipy) to estimate IC50 of anti-biofilm compounds. Classify biofilm formers using the standard ODc cutoff (mean abiotic + 3 SD).
Compare two conditions with an unpaired two-tailed t-test on biological-replicate means (n = 3); for multiple conditions use one-way ANOVA with Tukey's HSD (alpha = 0.05). For dose-response, compare fitted IC50 values with an F-test. Report effect sizes and 95% CIs. A priori power analysis (G*Power) targeting 80% power to detect a 30% biofilm change at alpha 0.05 typically requires n>=3 biological replicates given CV<20%. Treat technical replicates as nested, not independent.